Tag: acute pulmonary embolism
Imperative Care announces completion of enrolment in the SYMPHONY-PE study
Imperative Care today announced the completion of patient enrolment in its SYMPHONY-PE study, a pivotal investigational device exemption (IDE) trial evaluating the safety and...
Jupiter Endovascular announces US FDA approval for SPIRARE II pivotal trial
Jupiter Endovascular has announced that the US Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for the SPIRARE II US pivotal study. The pivotal trial will...
Catheter-directed mechanical thrombectomy system demonstrates safety and effectiveness in patients with...
Results from Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AX) finds significant improvement in right ventricle function and minimal major adverse events.
New...
Novel thrombectomy system demonstrates positive safety and feasibility results in treating...
Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The...
Anticoagulants effective for pulmonary embolism resolution in hospitalised COVID-19 patients
Anticoagulants alone are associated with a high rate of resolution of pulmonary embolism (PE) in patients with acute PE and COVID-19 infection. This was...